Vesalius is happy to support the Vancouver Westside FC Team, and especially one of our senior engineers (Michele Touchette) who plays on this team. We wish them a great season filled with success and lots of fun. Way to go Westside FC Team!

PCR London Valves is the cardiovascular european rendez-vous focussing on innovation in transcatheter therapies for valvular heart disease. This yearly event will take place at the ExCel London on November 27-29, 2022.  Vesalius has been selected by the Innovation...

The 7th annual Invest in BC event presented by Lumira Ventures will take place on November 2nd & 3rd, 2022. This event is an opportunity to bring together stakeholders in the healthcare innovation ecosystem and includes company pitches, presentations, and panel...

EuroPCR 2022 was a very successful event for Vesalius. In parallel to presenting during the Innovators' Day, Vesalius solution was published in EuroIntervention, the Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions...

Dr Peter Skarsgard, Vesalius President and Chief Scientific Officer, will be presenting Vesalius TMVr solution during the Innovators Day at EuroPCR in Paris on May 19th, 2022.    We believe mitral valve repair for simple or complex degenerative mitral regurgitation,...

During the Access to Innovation 2022 event organized by Lifesciences BC on February 16 and 17, our Chief Operating Officer Vincent Ledoux will be speaking on a panel relating to using IP to scale companies. This conference brings together leaders from across academia,...

Vesalius team celebrated today 5 years of next generation engineering and advanced biomedical innovations. Advancing medicine and simplifying the treatment for Mitral Regurgitation is and will always be our priority.